BIOSGN — Biosergen AB Share News
0.000.00%
Last trade - 00:00- SEK40.77m
- SEK37.53m
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million
Brief: Flerie, Biosergen Agree On Merger Plan
Brief: Biosergen Proposes Mattias Klintemar As Chairman Of Board Until Next AGM
Brief: Biosergen Pauses Development Of Bsg005
Sweden's Biosergen Q4 net loss widens as BSG005 advances
Brief: Biosergen Q4 EBITDA SEK -12.49 Million
Brief: Biosergen Resolved Record Date For Reverse Split
Brief: Biosergen Q3 EBITDA SEK -12.19 Million
Brief: Biosergen Q2 EBITDA SEK -11.039 Thousand
Brief: Biosergen Appoints Mark Beveridge As CFO
Brief: Biosergen Q4 Loss Narrows To SEK 3.7 Mln
Brief: Biosergen Conducts Directed Share Issue
Brief: Biosergen Says Receives About Sek 44.9 Mln Through Warrants Of Series TO3
Brief: Biosergen Q3 EBITDA Loss Narrows To SEK 4.3 Mln
Brief: Biosergen Safety Committee Approves To Dose Escalation In Bsg005 Clinical Trial
Brief: Biosergen Q2 EBITDA Loss Narrows To SEK 5.7 Million